Disease & disorder
hypoalphalipoproteinemia
MONDO:0017773
A metabolic disorder characterized by deficiency of high density (alpha) lipoprotein in the blood.
Research intelligence
Directly mapped studies only · unique clinical trialsCurrent registry observations. Phase counts may overlap. Study start dates are not registry registration dates. Investigational interventions are not approved-treatment recommendations.
Medications under investigation
Verified disease and drug mappings that co-occur within the same study; not evidence of effectiveness.
Loading mapped interventions…
MONDO disease family
Loading verified ontology relationships…
Recruiting studies by city
Loading research-site locations…
Trial status
Loading…
Trial phase
Loading…
Study start year
Loading…
Investigated drug interventions
Loading…
Background context
Hypoalphalipoproteinemia
Hypoalphalipoproteinemia (HA) is a high-density lipoprotein deficiency, inherited in an autosomal dominant manner. It can be associated with LDL receptor.
Background only. Canonical identity remains MONDO; clinical-trial relationships come from ClinicalTrials.gov.Drugs being studied
Disease identity and terminology: MONDO. Trial relationships: ClinicalTrials.gov.